Primary Care Respiratory Journal Primary Care Respiratory Group UK International Primary Care Respiratory Group Primary Care Respiratory Group UK International Primary Care Respiratory Group
Home
About the PCRJ
Articles in Press
Current Issue
All Issues
Translations
Alerts
Most popular articles
Editorial Board
Advertising
Search Tools
Disclaimer and Legal Notices

Volume 19 Issue 2 June 2010

Original Research

Pulmonary function testing in the Emergency Department and medications prescribed at discharge: results of the Multinational Acute asthma Management, Burden, and Outcomes (MAMBO) study

Pages 155-162
*J Mark Fitzgeralda, Paul M O'Byrneb, Jeffrey T McFetridgec, Dirk Demuthd, Felicia C Allen-Rameye

a Professor of Medicine, University of British Columbia (UBC), and Head, UBC and Vancouver General Hospital (VGH) Division of Respiratory Medicine, The Lung Centre, Gordon and Leslie Diamond Health Care Centre; and Director, Centre for Lung Health, University of British Columbia, Vancouver, BC, Canada

b Firestone Institute for Respiratory Health, St. Josephs Hospital, and the Department of Medicine, McMaster University, Hamilton, Ontario, Canada

c Department of Economics, Lehigh University, Bethlehem, PA, USA

d Adelphi Real World, Bollington, UK

e Global Outcomes Research, Merck & Co., Inc., Whitehouse Station, NJ, USA.

Received 6 May 2009 • Accepted 27 December 2009 • Online 26 January 2010


Abstract
AIMS: To evaluate asthma care in the emergency department (ED), including use of pulmonary function testing (PFT) and how patients are treated when discharged. METHODS: Internet-based surveys were completed by 298 healthcare practitioners in seven countries on 1078 patients 15-70 years old with an acute asthma exacerbation. RESULTS: Less than 60% of patients received guideline-recommended therapy with a bronchodilator, corticosteroid, and supplemental oxygen. Patients undergoing PFT had significantly more courses of asthma therapy (2.3 vs 1.7; p < 0.001), and received more medications (5.7 vs 3.9; p < 0.001). At discharge, 17.9% of patients did not receive a prescription asthma medication and 12.8% did not receive a physician referral. Men (p<0.022), patients with more severe disease (p<0.0001), and those seen by a pulmonologist (p<0.0001), were more likely to be treated. CONCLUSIONS: Management of patients with acute asthma exacerbations diverged from guideline recommendations. Enhanced adherence to guidelines could lead to improved outcomes.

Keywords
Asthma, exacerbation, guidelines, disease severity, treatment outcomes, assessment, drug therapy, emergency department, lung function

* Corresponding author. J Mark Fitzgerald Tel: 604-875-4122 Fax: 604-875-4695 Email: markf@interchange.ubc.ca
PDF View full text as PDF document

CrossRef Right click on this DOI link and copy link/shortcut to cite this article (What is a DOI link?)

Export Export to bibliographic software or plain text

CiteULike Post to CiteULike

Email this article Email this article to friend/s or colleague/s

Website developed and maintained by danzigdesigns.com